Clarivate Analytics plc (NYSE:CCC;CCC.WS), a global provider of trusted insights and analytics to accelerate innovation, acquired Darts-ip, a Brussels, Belgium-based provider of case law data and analytics for intellectual property (IP) professionals.
Kimaï, an Antwerp, Belgium-based direct-to-consumer fine jewelry brand, raised a $1.2m seed funding round.
Cashforce, an Antwerp, Belgium-based cash forecasting and working capital management solution provider, raised €5m in Series A funding.
iSTAR Medical SA, a Wavre, Belgium-based medical device company developing novel ophthalmic implants for the treatment of glaucoma, raised €40m in Series C financing.
Esoptra NV, a Herentals, Belgium-based DataOps company, raised €2.4m in funding.
Unifly NV, an Antwerp, Belgium-based provider of unmanned traffic management (UTM) software for drone enablement, completed a €17m Series B funding.
CryoTherapeutics, a Cologne, Germany-based and Awans, Belgium-based developer of cryotherapy systems for the treatment of coronary plaque, closed a €7m Series B equity, debt and grant financing.
Private equity firm Gimv acquires a majority stake in the Alro Group, a Dilsen-Stokkem – Belgium-based specialist in industrial coating of car and truck parts, in a family succession context.
Qover, a Belgian digital insurance company, completes an €8M funding round.
Showpad, a Ghent, Belgium- and Chicago, IL-based provider of a sales enablement solution, raised $70m in Series D debt and equity funding.
Imcyse, a Liège, Belgium-based developer of active specific immunotherapies for the treatment and prevention of severe chronic diseases, raised €35M ($39.5M) in Series B financing round and through other channels.
Tools4Patient, S.A., a Gosselies, Belgium-based developer of tools to optimize and accelerate drug development programs, raised €4m ($4.5m) in a Series B equity financing round.
icometrix, a Leuven, Belgium-based global expert in brain imaging Artificial Intelligence solutions, raised $18m in funding.
Confo Therapeutics, a Ghent, Belgium-based drug discovery company, completed a €30m ($33.4m) Series A financing.
Ulobby, a Copenhagen, Denmark- and Brussels, Belgium-based B2B SaaS-powered platform for Public Affairs and stakeholder relations management, raised a seed funding round of undisclosed amount.